Last updated: July 15, 2026

Application No. 18/501,324

DETERGENT COMPOSITIONS CONTAINING A XYLOGLUCANASE AND A HUEING DYE

Non-Final OA

Filed

Nov 03, 2023

Examiner

STEADMAN, DAVID J

Art Unit

1656

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

The Procter & Gamble Company

OA Round

1 (Non-Final)

This examiner grants 58% of cases after interview

— +29.6% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 963 resolved cases, 2023–2026

Examiner Intelligence

STEADMAN, DAVID J View full profile →

Grants 58% of resolved cases

Career Allowance Rate

555 granted / 963 resolved

-2.4% vs TC avg

Strong +30% interview lift

Without

With

+29.6%

Interview Lift

resolved cases with interview

Typical timeline

3y 1m

Avg Prosecution

55 currently pending

Career history

1017

Total Applications

across all art units

Statute-Specific Performance

§101

11.4%

-28.6% vs TC avg

§103

48.2%

+8.2% vs TC avg

§102

11.4%

-28.6% vs TC avg

§112

5.7%

-34.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 963 resolved cases

Prosecution Timeline

Nov 03, 2023

Application Filed

Apr 08, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/456,166

Patent 12674184

Processes and Systems for Catalytic Manufacture of Wax Ester Derivatives

4y 7m to grant Granted Jul 07, 2026

17/908,372

Patent 12674187

GRAM-POSITIVE BACTERIA OF THE SPECIES LACTOCOCCUS LACTIS OR STREPTOCOCCUS THERMOPHILUS HAVING A VERY LOW SURFACE PROTEOLYSIS, PROCESSES FOR OBTAINING THEM AND USES THEREOF

3y 10m to grant Granted Jul 07, 2026

18/044,250

Patent 12668786

ESTERASE AND METHODS OF USE, THEREOF

3y 3m to grant Granted Jun 30, 2026

17/527,429

Patent 12655411

MODIFIED STRAINS FOR THE PRODUCTION OF RECOMBINANT SILK

4y 7m to grant Granted Jun 16, 2026

18/666,610

Patent 12655368

Mannanase Variants and Polynucleotides Encoding Same

2y 1m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

58%

Grant Probability

87%

With Interview (+29.6%)

3y 1m (~5m remaining)

Median Time to Grant

Low

PTA Risk

Based on 963 resolved cases by this examiner. Grant probability derived from career allowance rate.